The FDA approves Somatuline® for the treatment of gastroenteropancreatic neuroendocrine tumors
(GEP-NETs). Learn more.
We are pleased to share a special nutrition program to help the pancreatic cancer community during the holidays. Learn more.
We are excited to have received Celgene’s 2014 Innovative Impact Award for our Know Your TumorSM initiative, which is under development. More information will be shared when the program is widely available. Learn more.